tradingkey.logo

Apyx Medical Corp

APYX

1.770USD

+0.020+1.14%
Horarios del mercado ETCotizaciones retrasadas 15 min
66.90MCap. mercado
PérdidaP/E TTM

Apyx Medical Corp

1.770

+0.020+1.14%
Más Datos de Apyx Medical Corp Compañía
Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and OEM. The Advanced Energy segment's product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It is focused on the cosmetic surgery market where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue to achieve their desired results. Its product lines consist of a multifunction generator, a handpiece and a supply of helium gas. The OEM segment leverages its expertise in the design, development and manufacturing of electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers through original equipment manufacturing agreements, as well as start-up companies with the need for its energy-based designs.
Información de la empresa
Símbolo de cotizaciónAPYX
Nombre de la empresaApyx Medical Corp
Fecha de salida a bolsaJul 22, 1983
Director ejecutivoMr. Charles D. Goodwin, II
Número de empleados220
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 22
Dirección5115 Ulmerton Rd
CiudadCLEARWATER
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal33760-4004
Teléfono18005372790
Sitio Webhttps://apyxmedical.com/
Símbolo de cotizaciónAPYX
Fecha de salida a bolsaJul 22, 1983
Director ejecutivoMr. Charles D. Goodwin, II
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
456.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy Levine
Ms. Wendy Levine
Independent Director
Independent Director
--
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
456.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
Domestic
6.74M
71.51%
International
2.69M
28.49%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: lun., 28 de jul
Actualizado: lun., 28 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
9.24%
Vanderfelt (William Weeks)
8.36%
Archon Capital Management LLC
8.24%
Royce Investment Partners
6.83%
Vizirgianakis (Stavros G)
4.62%
Other
62.70%
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
9.24%
Vanderfelt (William Weeks)
8.36%
Archon Capital Management LLC
8.24%
Royce Investment Partners
6.83%
Vizirgianakis (Stavros G)
4.62%
Other
62.70%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
18.35%
Individual Investor
14.56%
Investment Advisor
13.15%
Investment Advisor/Hedge Fund
11.82%
Private Equity
0.40%
Research Firm
0.07%
Family Office
0.05%
Other
41.60%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
116
22.05M
58.35%
-4.12M
2025Q1
125
22.61M
59.94%
-6.15M
2024Q4
130
22.74M
56.04%
-3.63M
2024Q3
136
20.12M
55.21%
-8.55M
2024Q2
151
21.12M
58.12%
-8.52M
2024Q1
177
21.34M
61.14%
-7.38M
2023Q4
188
22.63M
64.87%
-7.08M
2023Q3
183
23.85M
68.61%
-6.50M
2023Q2
175
23.83M
68.55%
-8.83M
2023Q1
178
25.32M
73.20%
-1.68M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Nantahala Capital Management, LLC
3.49M
9.24%
+235.19K
+7.22%
Jun 23, 2025
Vanderfelt (William Weeks)
3.16M
8.36%
--
--
Jun 23, 2025
Archon Capital Management LLC
3.12M
8.24%
-181.46K
-5.50%
Jun 23, 2025
Royce Investment Partners
2.58M
6.83%
+57.02K
+2.26%
Jun 23, 2025
Vizirgianakis (Stavros G)
1.75M
4.62%
--
--
Jun 23, 2025
The Vanguard Group, Inc.
1.48M
3.9%
--
--
Mar 31, 2025
Silverberg Bernstein Capital Management, LLC
646.57K
1.71%
+75.34K
+13.19%
Mar 31, 2025
Horizon Kinetics LLC
615.00K
1.63%
--
--
Mar 31, 2025
Commonwealth Financial Network
585.54K
1.55%
+58.48K
+11.10%
Mar 31, 2025
Worth Venture Partners, LLC
518.20K
1.37%
+55.59K
+12.02%
Dec 31, 2023
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0.02%
Avantis US Equity ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
Proporción0.02%
Avantis US Equity ETF
Proporción0%
Invesco NASDAQ Future Gen 200 ETF
Proporción0%
Avantis US Small Cap Equity ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI